why choose us

First received: August 09, 2024

Clinical Trial: The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Syncytial Virus Infection

Study Type: INTERVENTIONAL


Official Title: A Prospective, Randomized, Open-label Phase 4 Study of the Immunology and Safety of Maternal RSV Vaccination (ABRYSVO (TM)), Infant Nirsevimab (BEYFORTUS (TM)) Immunization, or Both Products During th

Brief Summary: Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract infections (LRTIs) in infants and young children. It is also a leading cause of mortality in children \

Read more